Literature DB >> 26343608

The Hamburg-Hannover Agitation Scale (H2A): Development and validation of a self-assessment tool for symptoms of agitation.

Stefanie Jung1, M Axel Wollmer2, Tillmann H C Kruger3.   

Abstract

BACKGROUND: Agitation has long been underestimated as a symptom occurring across psychiatric disorders. While several instruments exist for highly specific clinical target groups (e.g., dementia, traumatic brain injury), no tool captures agitation in a broader range of psychiatric patients. The Hamburg-Hannover Agitation Scale (H2A) has been designed to satisfy this demand. This study concentrated on the development and validation of the scale in a psychiatric and a healthy control sample.
METHODS: The H2A was developed, tested in an expert sample, and revised. The German version was validated in a study involving two clinical institutions. Patients (n = 180) completed the H2A and several other questionnaires in order to test for congruent and discriminant validity. Healthy subjects (n = 685) completed the H2A only. The H2A was translated into English.
RESULTS: The H2A showed very satisfying quality criteria (reliability, selectivity, item difficulty) and regression analysis demonstrated the H2A's ability to distinguish between subjects with a psychiatric diagnosis and healthy subjects with or without psychiatric record. Factor analysis revealed a three-factorial structure representing a physiological/somatic, a mental and a mixed ('psychophysiological') dimension of agitation. LIMITATIONS: Although validation showed promising quality criteria and predictive value of the H2A, calibration tests with bigger and more balanced sample sizes are necessary.
CONCLUSIONS: Agitation has become more clinically relevant as a symptom occurring in various affective disorders, yet its assessment is limited. The H2A was developed in order to meet this need. Validation of the H2A revealed very satisfactory item and scale quality criteria promoting its utility.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Agitation; Assessment; Manifestation; Prediction; Questionnaire; Symptom

Mesh:

Year:  2015        PMID: 26343608     DOI: 10.1016/j.jpsychires.2015.08.006

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

1.  [Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].

Authors:  T H C Krüger; M A Wollmer; P Negt; H Frieling; S Jung; K G Kahl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

2.  Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder.

Authors:  Tillmann H C Kruger; Jara Schulze; Christopher Sinke; M Axel Wollmer; Agnès Bechinie; Insa Neumann; Stefanie Jung; Christian Sperling; Jannis Engel; Antje Müller; Jonas Kneer; Kai G Kahl; Matthias Karst; Julian Herrmann; Larissa Fournier-Kaiser; Liza Peters; Frank Jürgensen; Matthias Nagel; Welf Prager; Birger Dulz; Peter Wohlmuth; Volker Heßelmann
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

3.  Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.

Authors:  Mohammad Ahmadpanah; Meisam Sheikhbabaei; Mohammad Haghighi; Fatemeh Roham; Leila Jahangard; Amineh Akhondi; Dena Sadeghi Bahmani; Hafez Bajoghli; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-07       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.